Background Age-specific incidence of acute myocarditis/pericarditis in adolescents following
Comirnaty vaccination in Asia is lacking. This study aimed to study the clinical characteristics …

Aims While some concerns about vaccination-related pericarditis and/or myocarditis have
been raised, no published data are available on pericarditis and/or myocarditis with mRNA …

An increasing number of myocarditis/pericarditis incidences has been reported after
coronavirus disease-19 (COVID-19) vaccination in adolescents and young adults. This study …

In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-
BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between …

Trials of coronavirus disease 2019 (COVID-19) vaccination included limited numbers of
children, so they may not have detected rare but important adverse events in this population …

Background: Understanding the clinical course and short-term outcomes of suspected
myocarditis after the coronavirus disease 2019 (COVID-19) vaccination has important public …

Aims A comprehensive nationwide study on the incidence and outcomes of COVID-19
vaccination-related myocarditis (VRM) is in need. Methods and results Among 44 276 704 …

Importance Published data on COVID-19 mRNA vaccine–associated myopericarditis in
adolescents and young adults have been derived from small case series, national …

Background: Vaccines are paramount in the effort to end the coronavirus disease 2019
global epidemic. BNT162b2 is approved for the vaccination of adolescents over 16 years of …

This is a cross-sectional study of 29 published cases of acute myopericarditis following
COVID-19 mRNA vaccination. The most common presentation was chest pain within 1–5 …